SYRMA.NS(SYRMA.NS)
SYRMA.NS
No analyst ratings available
No analyst price targets available for SYRMA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $64.29B | $83.77B | $105.42B | $111.95B |
| Low | $61.83B | $78.71B | $104.90B | $106.27B |
| High | $71.21B | $88.98B | $105.94B | $121.13B |
| EBITDA Avg | $7.35B | $9.57B | $12.05B | $12.80B |
| Low | $7.07B | $9.00B | $11.99B | $12.15B |
| High | $8.14B | $10.17B | $12.11B | $13.85B |
| EBIT Avg | $6.19B | $8.06B | $10.15B | $10.77B |
| Low | $5.95B | $7.57B | $10.10B | $10.23B |
| High | $6.85B | $8.56B | $10.19B | $11.66B |
| Net Income Avg | $4.02B | $5.44B | $7.04B | $8.19B |
| Low | $3.73B | $4.62B | $6.88B | $7.65B |
| High | $4.80B | $6.27B | $8.40B | $9.06B |
| EPS Avg | $21.85 | $29.06 | $39.03 | $42.80 |
| Low | $19.50 | $24.18 | $35.95 | $39.98 |
| High | $25.09 | $32.77 | $43.93 | $47.36 |
| Analysts (Rev / EPS) | 16 / 14 | 16 / 14 | 7 / 6 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $14.37B | $16.34B | $19.87B |
| Low | $14.37B | $16.34B | $19.87B |
| High | $14.37B | $16.34B | $19.87B |
| EBITDA Avg | $1.64B | $1.87B | $2.27B |
| Low | $1.64B | $1.87B | $2.27B |
| High | $1.64B | $1.87B | $2.27B |
| EBIT Avg | $1.38B | $1.57B | $1.91B |
| Low | $1.38B | $1.57B | $1.91B |
| High | $1.38B | $1.57B | $1.91B |
| Net Income Avg | $956M | $1.17B | $1.53B |
| Low | $956M | $1.17B | $1.53B |
| High | $956M | $1.17B | $1.53B |
| EPS Avg | $5.00 | $6.10 | $8.00 |
| Low | $5.00 | $6.10 | $8.00 |
| High | $5.00 | $6.10 | $8.00 |
| Analysts (Rev / EPS) | 10 / 1 | 11 / 1 | 6 / 1 |